What Menopause Actually Is
Menopause is a single point in time — the day twelve consecutive months have passed since a woman's last menstrual period. Everything before is perimenopause; everything after is postmenopause. In the United States, the average age is approximately 51, with a normal range from roughly 45 to 55.
Menopause before 45 is considered early menopause, and before 40 is called premature ovarian insufficiency — both warrant a fuller workup. Surgical menopause, induced by removal of the ovaries, produces an abrupt rather than gradual hormonal shift and is generally more symptomatic.
The Symptom Picture
Most of what patients describe as 'menopause symptoms' are driven by the sustained decline in estrogen, progesterone, and testosterone that follows the final menstrual period. These symptoms can persist for many years if left unaddressed.
- Vasomotor symptoms: hot flashes and night sweats
- Sleep disruption, often waking at 2–3 a.m.
- Mood changes including new or worsening anxiety
- Cognitive complaints — word-finding, focus, memory
- Vaginal dryness and painful intercourse
- Declining libido
- Body composition changes — loss of muscle, increased abdominal fat
- Joint aches, skin thinning, hair changes
- Increased long-term risk of osteoporosis and cardiovascular disease
Treatment Options Today
Modern hormone therapy is meaningfully different from the protocols studied two decades ago in the Women's Health Initiative. We now use bio-identical estradiol and micronized progesterone — molecules identical to those the body makes — and we increasingly favor transdermal delivery, which bypasses first-pass liver metabolism and lowers thromboembolic risk compared to oral estrogen.
For women under 60 or within 10 years of menopause without significant contraindications, the risk-benefit profile of hormone therapy is favorable for symptom relief and bone protection. Low-dose testosterone is added when appropriate, particularly for libido, muscle preservation, and energy.
Non-hormonal options exist for women who cannot or prefer not to use estrogen: certain SSRIs and SNRIs, gabapentin, and the newer neurokinin-3 receptor antagonists for vasomotor symptoms. Vaginal estrogen, used locally, has a different risk profile than systemic estrogen and is appropriate for many women with genitourinary symptoms.
What a Thoughtful Evaluation Looks Like
An evaluation includes a complete symptom history, personal and family medical history, and targeted labs — typically a thyroid panel, ferritin, CBC, comprehensive metabolic panel, lipids, vitamin D, and sex hormones interpreted in context. Bone density and cardiovascular risk assessment are appropriate at this stage of life.
Treatment decisions are individualized. The right plan depends on symptoms, risk factors, preferences, and goals — which is why the consultation matters more than any single lab value.
What This Guide Cannot Replace
Education is the starting point. Hormone therapy decisions depend on individual factors that cannot be captured in a written guide. Atlas & Willow offers private, unhurried consultations in Clarksville, TN for women navigating the menopausal transition.